These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1421 related articles for article (PubMed ID: 25888948)
1. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer. Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947 [TBL] [Abstract][Full Text] [Related]
4. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268 [TBL] [Abstract][Full Text] [Related]
7. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel. Wang X; Cheng R; Zhong Z Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162 [TBL] [Abstract][Full Text] [Related]
8. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells. Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles. Giarra S; Serri C; Russo L; Zeppetelli S; De Rosa G; Borzacchiello A; Biondi M; Ambrosio L; Mayol L Carbohydr Polym; 2016 Apr; 140():400-7. PubMed ID: 26876867 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting. Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660 [TBL] [Abstract][Full Text] [Related]
15. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
16. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting. Park JH; Cho HJ; Kim DD Int J Nanomedicine; 2017; 12():7453-7467. PubMed ID: 29066894 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of biodegradable nanoparticles as antigen delivery system. Petrizzo A; Conte C; Tagliamonte M; Napolitano M; Bifulco K; Carriero V; De Stradis A; Tornesello ML; Buonaguro FM; Quaglia F; Buonaguro L J Exp Clin Cancer Res; 2015 Oct; 34():114. PubMed ID: 26444005 [TBL] [Abstract][Full Text] [Related]
18. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging. Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]